Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy

被引:0
|
作者
ZHANG Bo LIU Zhihong ZENG Caihong ZHENG Jingmin CHEN Huiping ZHOU Hong and LI LeishiResearch Institute of Nephrology Jingling Hospital Nanjing University School of Medicine Nanjing ChinaDepartment of Nephrology First Affiliated Hospital of Nanjing Medical University Nanjing China [210002 ,210029 ]
机构
关键词
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
摘要
Background Lipoprotein glomerulopathy (LPG) is a renal disease characterized by thrombus-like lipoproteins in the glomerular capillaries and its abnormal lipoprotein profiles with marked elevation of apolipoprotein E (apoE). In this study, 15 Chinese patients with LPG were involed in exploring the association of the genetic variation and its plasma level in the pathogenesis of LPG.Methods A retrospective analysis of the clinical and pathological features was made in 15 patients with LPG. Plasma concentrations of apoE were measured with radial immunodiffusion assay. Genetic variations of apoE gene were detected using polymerase chain reaction and restriction fragment length polymorphism. Glomerular deposition of apoA, apoB and apoE in these patients were detected by immunofluorescence staining using monoclonal antibodies. Results Biochemical profiles of lipids and lipoproteins revealed markedly elevated levels of triglyceride, apoB and apoE, but approximately normal levels of total cholesterol, apoA1 and lipoprotein(a) [Lp(a)], which resembled familial hypertriglyceridemia. Genetic analysis demonstrated that the genotype distribution of apoE were 7 cases with (ε3/ε 4,)4 cases with ε3/ε 3 and 2 cases with ε2/ε 3. The other 2 cases (a mother and her son) showed a same distinct band. The band pattern of later 2 cases was quite similar to the apoE variant of Tokyo type. The calculated allele frequency of ε 4 was relatively high in cases with LPG in comparison with that in the normal controls. We further divided the 13 patients into three groups according to their genotypes of apoE. Patients with the genotype of apoE ε2/ε3 showed a lower level of plasma apoE as compared to those with apoE ε3/ε4 (P<0.05). The serum level of high-density lipoprotein (HDL) was the lowest in patients with the genotype of apoE ε3/ε4. No difference was found among the patients with different apoE genotype in the other clinical and pathological characteristics. Conclusions The genotype of apoE ε3/ε4 is the predominant one in Chinese patients with LPG. Patients with this genotype tend to have a higher plasma level of apoE and more severe lipid dysmetabolism. No correlation was found between the genotype of apoE and the clinical features in patients with LPG.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [31] A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy
    Matsunaga, A
    Sasaki, J
    Komatsu, T
    Kanatsu, K
    Tsuji, E
    Moriyama, K
    Koga, T
    Arakawa, K
    Oikawa, S
    Saito, T
    Kita, T
    Doi, T
    KIDNEY INTERNATIONAL, 1999, 56 (02) : 421 - 427
  • [32] A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy
    Hayakawa, M
    Okubo, M
    Katori, H
    Nagahama, K
    Murase, T
    Kobayashi, T
    Tanaka, S
    Nakanishi, K
    Odawara, M
    Matsushita, H
    Yamada, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03)
  • [33] ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING NORMAL PLASMA-LIPID AND LIPOPROTEIN VARIATION
    SING, CF
    DAVIGNON, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1985, 37 (02) : 268 - 285
  • [34] Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney
    Miyata, T
    Sugiyama, S
    Nangaku, M
    Suzuki, D
    Uragami, KI
    Inagi, R
    Sakai, H
    Kurokawa, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (07): : 1590 - 1595
  • [35] IMPACT OF APOLIPOPROTEIN-E GENOTYPE VARIATION ON MEANS, VARIANCES, AND CORRELATIONS OF PLASMA-LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN TRAITS IN OCTOGENARIANS
    HAVILAND, MB
    LUSSIERCACAN, S
    DAVIGNON, J
    SING, CF
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (04): : 315 - 331
  • [36] Apolipoprotein E Sendai (arginine 145->proline): A new variant associated with lipoprotein glomerulopathy
    Oikawa, S
    Matsunaga, A
    Saito, T
    Sato, H
    Seki, T
    Hoshi, K
    Hayasaka, K
    Kotake, H
    Midorikawa, H
    Sekikawa, A
    Hara, S
    Abe, K
    Toyota, T
    Jingami, H
    Nakamura, H
    Sasaki, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (05): : 820 - 823
  • [37] Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy
    Luo, Boxun
    Huang, Fengxian
    Liu, Qicai
    Li, Xiaoyan
    Chen, Wenfang
    Zhou, Shu-Feng
    Yu, Xueqing
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (02) : 347 - 353
  • [38] Lipoprotein glomerulopathy with a novel apolipoprotein E variant, APOE Kanto (Asp 151dup)
    Yokochi, Akio
    Matsunaga, Akira
    Kanemoto, Keiko
    Tominaga, Naoto
    Uda, Susumu
    Saito, Takao
    CEN CASE REPORTS, 2024, : 162 - 166
  • [39] LIPOPROTEIN GLOMERULOPATHY: AN EXCEPTIONAL DISEASE IN CAUCASIAN PEOPLE : A FRENCH CASE WITH APOLIPOPROTEIN E CHICAGO MUTATION
    Bailly, Elodie
    Pierre, Dominique
    Kerdraon, Remy
    Grezard, Olivier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 404 - 404
  • [40] Lipoprotein glomerulopathy: A new apolipoprotein-E-related disease that recurs after renal transplantation
    Mourad, G
    Cristol, JP
    TurcBaron, C
    Djamali, A
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (05) : 2376 - 2376